Company intelligence / Profile preview
Normax
New York, New York, United Statesnormax.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Normax is a biotechnology company dedicated to developing and manufacturing affordable, high-quality vaccines for global health challenges, with a primary focus on infectious diseases. The company gained prominence for its "People's Vaccine" initiative, which aims to provide low-cost COVID-19 vaccines to underserved populations through a decentralized manufacturing model. Beyond COVID-19, Normax is working on a pipeline that includes candidates for tuberculosis and other high-burden diseases. Their business model emphasizes technology transfer and local production to ensure equitable access to life-saving immunizations.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineProteinRecombinant protein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Serum Institute of IndiaGenoa Biopharmaceuticals
Beyond the preview
Go deeper on Normax.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Normax.